atopic dermatitis (eczema) Clinical Trials

10 recruitingLast updated: June 17, 2026

There are 10 actively recruiting atopic dermatitis (eczema) clinical trials across 8 countries. Studies span Phase 2, Not Applicable, Phase 3, Phase 4. Top locations include New Taipei City, Taiwan, Beijing, China, Benowa, Queensland, Australia. Updated daily from ClinicalTrials.gov.


atopic dermatitis (eczema) Trials at a Glance

10 actively recruiting trials for atopic dermatitis (eczema) are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in New Taipei City, Beijing, and Benowa. Lead sponsors running atopic dermatitis (eczema) studies include Alphyn Biologics, Corvus Pharmaceuticals, Inc., and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse atopic dermatitis (eczema) trials by phase

Treatments under study

About atopic dermatitis (eczema) Clinical Trials

Looking for clinical trials for atopic dermatitis (eczema)? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new atopic dermatitis (eczema) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about atopic dermatitis (eczema) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis

atopic dermatitis (eczema)
Zhongda Hospital80 enrolled1 locationNCT07573735
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

atopic dermatitis (eczema)Atopic DermatitisEczema
Inmagene LLC405 enrolled23 locationsNCT07037901
Recruiting

Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.

atopic dermatitis (eczema)Atopic Dermatitis (AD)
Hôpitaux Drôme Nord15 enrolled1 locationNCT07568665
Recruiting
Phase 2

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

atopic dermatitis (eczema)Atopic DermatitisEczema+1 more
Corvus Pharmaceuticals, Inc.200 enrolled1 locationNCT07441395
Recruiting
Phase 4

DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema

atopic dermatitis (eczema)Atopic Dermatitis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)216 enrolled2 locationsNCT06004986
Recruiting
Phase 2

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

atopic dermatitis (eczema)Atopic DermatitisEczema+2 more
Alphyn Biologics72 enrolled12 locationsNCT06855745
Recruiting
Not Applicable

Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis

atopic dermatitis (eczema)Atopic Dermatitis, Probiotics
Taipei Medical University Shuang Ho Hospital120 enrolled2 locationsNCT06636240
Recruiting
Phase 2Phase 3

Herbal Ointment in Treating Atopic Dermatitis Topically

atopic dermatitis (eczema)Atopic DermatitisAtopic Dermatitis (AD)+4 more
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

atopic dermatitis (eczema)Prurigo Nodularis
Peking University First Hospital100,000 enrolled1 locationNCT05316805
Recruiting
Not Applicable

Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals

atopic dermatitis (eczema)AgingDiet Modification
National University of Singapore44 enrolled1 locationNCT06454942